However, we cannot decipher whether it results of MYCN direct effect on HLA-gene expression in tumor cells, or from an indirect effect due to CCL2 downregulation, resulting in low immune cell infiltration and inflammation. The gene discussed is CCL2; the disease is neoplasm.